OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Immunology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Recent advances in mRNA vaccine technology	292
COVID-19 vaccines	183
DNA vaccines: prime time is now	120
Type I interferon in the pathogenesis of systemic lupus erythematosus	104
The NLRP3 inflammasome triggers sterile neuroinflammation and Alzheimer’s disease	92
Tryptophan and indole metabolism in immune regulation	85
Shaping humoral immunity to vaccines through antigen-displaying nanoparticles	78
Cross-presentation of exogenous antigens on MHC I molecules	76
Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy	70
Vaccine hesitancy in migrant communities: a rapid review of latest evidence	63
Food allergy: epidemiology, pathogenesis, diagnosis, prevention, and treatment	62
Conserved strategies for pathogen evasion of cGAS–STING immunity	56
Mechanisms of non-type 2 asthma	55
Ebola virus disease: current vaccine solutions	54
The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention	48
Type I interferons and SARS-CoV-2: from cells to organisms	48
The role of CD4 T cells in rejection of solid tumors	48
The politics of Covid-19 vaccine confidence	47
Metabolic control of B cell immune responses	47
Natural killers or ILC1s? That is the question	45
A critical review of measures of childhood vaccine confidence	45
CBASS phage defense and evolution of antiviral nucleotide signaling	44
Innovations in structure-based antigen design and immune monitoring for next generation vaccines	43
Cytokines and transcription factors in the differentiation of CD4+ T helper cell subsets and induction of tissue inflammation and autoimmunity	43
The multifaceted functions of follicular regulatory T cells	41

Commensal bacteria in the upper respiratory tract regulate susceptibility to infection	41
Detrimental activation of AhR pathway in cancer: an overview of therapeutic strategies	41
HLA variation and antigen presentation in COVID-19 and SARS-CoV-2 infection	40
Innate lymphoid cells: from helper to killer	40
Anti-interferon-γ autoantibody-associated immunodeficiency	39
Exploring cardiac macrophage heterogeneity in the healthy and diseased myocardium	39
The high affinity IgE receptor: a signaling update	39
Sensing and clearance of apoptotic cells	38
The innate immune system and cell death in autoinflammatory and autoimmune disease	37
Tuning tuft cells: new ligands and effector functions reveal tissue-specific function	37
Membrane cofactor protein (MCP; CD46): deficiency states and pathogen connections	36
Inhibitory receptor agonists: the future of autoimmune disease therapeutics?	36
The host targeting effect of chloroquine in malaria	35
Recent advances in atopic dermatitis	35
Regulation of host physiology and immunity by microbial indole-3-aldehyde	34
Protective and pathogenic roles for mast cells during viral infections	33
New horizons in adjuvants for vaccine development	32
Inborn errors of STAT1 immunity	32
New insights into B cells as antigen presenting cells	32
Gut microbiome-mediated regulation of neuroinflammation	31
Trained immunity: implications for vaccination	31
Selection in the germinal center	30
Viral vector vaccines	30
Signals governing monocyte differentiation during inflammation	30
MHC I assembly and peptide editing — chaperones, clients, and molecular plasticity in immunity	29
New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression	28
Diversity and function of brain-associated macrophages	28
Interventions for vaccine hesitancy	27
IgM memory B cells: specific effectors of innate-like and adaptive responses	27
Integrating resident memory into T cell differentiation models	27
Intrinsic and extrinsic regulation of IgE B cell responses	27
Tryptophan metabolism in brain tumors — IDO and beyond	27
DRiPs get molecular	27
Mast cell tryptases in allergic inflammation and immediate hypersensitivity	26
There is no gene for CVID — novel monogenetic causes for primary antibody deficiency	26
Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs	25
Supply and delivery of vaccines for global health	25
Role of the NF-κB system in context-specific tuning of the inflammatory gene response	25
Major histocompatibility complex (MHC) class I and class II proteins: impact of polymorphism on antigen presentation	25
Inborn errors of IL-6 family cytokine responses	25
Regulation of innate immunity by Nrf2	25
Innate immune defenses at the maternal-fetal interface	24
Charcot–Leyden crystals and other protein crystals driving type 2 immunity and allergy	24
Emerging roles of circular RNAs in innate immunity	24
The epigenetically-encoded memory of the innate immune system	24
Adverse events induced by immune checkpoint inhibitors	24
Mechanisms for control of skin immune function by the microbiome	24
Leishmania Viannia guyanensis, LRV1 virus and extracellular vesicles: a dangerous trio influencing the faith of immune response during muco-cutaneous leishmaniasis	23
Biologic treatment options for severe asthma	23
Inflammasome activation and evasion by bacterial pathogens	23

Mycobacterial diseases in patients with inborn errors of immunity	23
TACI deficiency — a complex system out of balance	22
Emerging technologies for systems vaccinology — multi-omics integration and single-cell (epi)genomic profiling	22
Epigenetics of T cell fate decision	21
Therapeutic induction of tolerogenic dendritic cells via aryl hydrocarbon receptor signaling	20
Structural and dynamic studies of TAPBPR and Tapasin reveal the mechanism of peptide loading of MHC-I molecules	20
HBV as a target for CAR or TCR-T cell therapy	20
The role of enteric glia in intestinal immunity	19
Down syndrome and type I interferon: not so simple	19
Immunity to EBV as revealed by immunedeficiencies	19
Resistance mechanisms to checkpoint inhibitors	19
New function of zebrafish regulatory T cells in organ regeneration	19
Reflection: burden of cervical cancer in Sub-Saharan Africa and progress with HPV vaccination	18
CD4+ teff cell heterogeneity: the perspective from single-cell transcriptomics	18
Dendritic cells and the skin environment	18
BAFF signaling in health and disease	18
Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infection	18
Virus-encoded cytokine and chemokine decoy receptors	17
Mechanisms of response and resistance to CAR T cell therapies	17
T cell immunity to cytomegalovirus infection	17
New insights into human immunity from ancient genomics	17
Atypical B cells in chronic infectious diseases and systemic autoimmunity: puzzles with many missing pieces	17
Principles and practical applications of structure-based vaccine design	17
The double life of serotonin metabolites: in the mood for joining neuronal and immune systems	17
The fibroblastic T cell niche in lymphoid tissues	17
Innate immune sensing by epithelial barriers	16
Infection and cancer suppress pDC derived IFN-I	16
Cross-reactivity between microbial and tumor antigens	16
The burgeoning role of MR1-restricted T-cells in infection, cancer and autoimmune disease	16
Immune checkpoint receptors in autoimmunity	16